Long-awaited diet pill gets U.S. approval

September 11, 2014 1:01 AM

21 0

Sept 10 (Reuters) - A new diet pill Contrave got approval to be sold in the United States on Wednesday, only the third obesity treatment in more than a decade to win approval from the Food and Drug Administration.

Made by Orexigen Therapeutics Inc, Contrave is a combination of the antidepressant bupropion and Orexigen's formulation of naltrexone, designed to prevent drug dependence. (1.usa.gov/1wguwo4)

Read more

To category page